title: Epilepsy, progessive movement disorder and cognitive decline.
authors.affiliation: Neuropsychiatry Unit, Melbourne Neuropsychiatry Centre, University of Melbourne and North-Western Mental Health, Royal Melbourne Hospital, Parkville, Melbourne, Victoria 3052, Australia. brent.robertson@mh.org.au
authors.forename: B
authors.initials: B
authors.lastname: Robertson
authors.forename: A H
authors.initials: AH
authors.lastname: Evans
authors.forename: M
authors.initials: M
authors.lastname: Walterfang
authors.forename: A P
authors.initials: AP
authors.lastname: Ng
authors.forename: D
authors.initials: D
authors.lastname: Velakoulis
mesh_terms: D000328:Adult; D001284:Atrophy / Q000209:etiology / Q000473:pathology; D001480:Basal Ganglia Diseases / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D003072:Cognition Disorders / Q000209:etiology*; D015897:Comorbidity; D003937:Diagnosis, Differential; D018450:Disease Progression; D004827:Epilepsy / Q000209:etiology*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008279:Magnetic Resonance Imaging; D009069:Movement Disorders / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D009154:Mutation / Q000235:genetics; D054546:Neuroacanthocytosis / Q000150:complications* / Q000175:diagnosis* / Q000503:physiopathology; D011379:Prognosis; D033921:Vesicular Transport Proteins / Q000235:genetics
chemical_list: C429654:VPS13A protein, human; D033921:Vesicular Transport Proteins